Karim Rahimi

589 total citations
25 papers, 398 citations indexed

About

Karim Rahimi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karim Rahimi has authored 25 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karim Rahimi's work include MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). Karim Rahimi is often cited by papers focused on MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). Karim Rahimi collaborates with scholars based in Denmark, Iran and United States. Karim Rahimi's co-authors include Jørgen Kjems, Morten T. Venø, Daniel M. Dupont, Mohammad Abdi, Abbas Ahmadi, Samira Mohammadi‐Yeganeh, Fardin Fathi, Thomas B. Hansen, Rei Yoshimoto and Akila Mayeda and has published in prestigious journals such as Nature Communications, Biomaterials and Scientific Reports.

In The Last Decade

Karim Rahimi

25 papers receiving 394 citations

Peers

Karim Rahimi
Comparison fields: 5 of 64
  • Molecular Biology 342
  • Cancer Research 221
  • Oncology 33
  • Plant Science 16
  • Biomaterials 15
Replace Li Tan with:
Li Tan China
Jiatong Lin China
Tanu Singh United States
Haitao Yin China
Yingya Wu China
Shixiong Jiang China
Zhiwen Li China
Xiaoping Wu China
Li Tan China View profile →
Citations per field, relative to Karim Rahimi
Karim Rahimi · 1×
Citations per year, relative to Karim Rahimi
Karim Rahimi · 1×

Countries citing papers authored by Karim Rahimi

Since Specialization
Citations

This map shows the geographic impact of Karim Rahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Rahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Rahimi more than expected).

Fields of papers citing papers by Karim Rahimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Rahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Rahimi. The network helps show where Karim Rahimi may publish in the future.

Co-authorship network of co-authors of Karim Rahimi

This figure shows the co-authorship network connecting the top 25 collaborators of Karim Rahimi. A scholar is included among the top collaborators of Karim Rahimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Rahimi. Karim Rahimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 5
2 4
3 1
4 3
5 6
6 3
7 1
8 9
9 7
10 21
11 87
12 33
13 30
14 13
15 2
16 7
17 46
18 11
19 5
20 9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026